speb/financial-data huggingface dataset:
Financial ratios for KALA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -10328000
Net income: -11155000
Capital expenditures: 16000
Operating cash flow: -7734000
Depreciation & amortization: 67000
Net tangible assets: -3206000
Owner earnings: -11104000
Buffett classification: The Gruesome
Stock price: 238
Shares outstanding: 18589787
Book value: -3206000
Market cap (USD): 4424369306
Debt to equity: -9.335620711166563
Current ratio: 2.101835664335664
Quick ratio: 2.101835664335664
Interest coverage ratio: -9.554116558741905
Free cash flow (dilution-adjusted): -9990000
Buyback yield (%): 0
Retained earnings: -688022000
Receivables turnover: 0
Capitalized R&D asset: 10288850
ROCI (R&D-adjusted, %): -27.012158494046055
Rule of 40 score: 0
Financial ratios for KALA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -10181000
Net income: -7564000
Capital expenditures: 1000
Operating cash flow: -10877000
Depreciation & amortization: 128000
Net tangible assets: -8665000
Owner earnings: -7437000
Buffett classification: The Gruesome
Stock price: 76.5
Shares outstanding: 18589787
Book value: -8665000
Market cap (USD): 1422118705.5
Debt to equity: -3.4556260819388345
Current ratio: 0.7451955547369067
Quick ratio: 0.7451955547369067
Interest coverage ratio: -10.572170301142263
Free cash flow (dilution-adjusted): -12920000
Buyback yield (%): 0
Retained earnings: -695586000
Receivables turnover: 0
Capitalized R&D asset: 12300590
ROCI (R&D-adjusted, %): -214.67734155645286
Rule of 40 score: 0
Financial ratios for KALA — annual report dated 2025-12-31
Total revenue: 0
Operating income: -39032000
Net income: -26980000
Capital expenditures: 15000
Operating cash flow: -31991000
Depreciation & amortization: 317000
Net tangible assets: 6996000
Owner earnings: -26678000
Return on net tangible assets (%): -381.3321898227559
Buffett classification: The Gruesome
Stock price: 27.8
Shares outstanding: 18589787
Book value: 6996000
P/B ratio: 73.87022278444826
Market cap (USD): 516796078.6
Debt to equity: 0
Current ratio: 3.805132317562149
Quick ratio: 3.805132317562149
Interest coverage ratio: -11.914529914529915
Free cash flow (dilution-adjusted): -39001000
Buyback yield (%): 0
Retained earnings: -694900000
Capitalized R&D asset: 39716360
ROCI (R&D-adjusted, %): -85.78457607365588
Rule of 40 score: 0
Financial ratios for KALA — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -10225000
Net income: 686000
Capital expenditures: 0
Operating cash flow: -4556000
Depreciation & amortization: 54000
Net tangible assets: 6996000
Owner earnings: 740000
Return on net tangible assets (%): 10.577472841623784
Buffett classification: The Gruesome
Stock price: 27.8
P/E ratio: 188.33676333819244
Shares outstanding: 18589787
Book value: 6996000
P/B ratio: 73.87022278444826
Market cap (USD): 516796078.6
Debt to equity: 0
Current ratio: 3.805132317562149
Quick ratio: 3.805132317562149
Interest coverage ratio: -72.51773049645391
Free cash flow (dilution-adjusted): -4957000
Buyback yield (%): 0
Retained earnings: -694900000
Capitalized R&D asset: 6527650
ROCI (R&D-adjusted, %): -104.26672286451266
Rule of 40 score: 0
Financial ratios for KURN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.10989010989011
Shares outstanding: 39439421
Market cap (USD): 83212844.3076923
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KURN.SW — annual report dated 2022-12-31
Total revenue: 19550000
Gross profit: 11705434.782608695
Operating income: -14615217.391304348
Net income: -15864130.434782607
Capital expenditures: 428260.86956521735
Operating cash flow: -7986956.52173913
Depreciation & amortization: 3080434.7826086953
Net tangible assets: 21884782.608695652
Owner earnings: -13211956.521739129
Return on net tangible assets (%): -60.370517532532034
Buffett classification: The Gruesome
Stock price: 1.5978260869565217
Shares outstanding: 39439421
Book value: 74847826.08695652
P/B ratio: 0.8419394259366831
Market cap (USD): 63017335.72826087
Debt to equity: 0.02778100493755446
Current ratio: 2.4936849630629916
Quick ratio: 2.241877829851458
Interest coverage ratio: -92.73103448275862
COGS to revenue (%): 40.12565328588902
R&D to revenue (%): 28.878016234849323
SG&A to revenue (%): 62.00934059824308
Free cash flow (dilution-adjusted): -9541304.347826086
Buyback yield (%): 0
Retained earnings: -126361956.52173913
Inventory turnover: 2.2766561514195582
Receivables turnover: 6.384806531771388
Capitalized R&D asset: 5645652.173913043
ROCI (R&D-adjusted, %): -13.214032022519003
FCF margin (%): -48.80462582008228
Rule of 40 score: -48.80462582008228
Financial ratios for KURN.SW — annual report dated 2023-12-31
Total revenue: 39957142.85714286
Gross profit: 28495238.095238097
Operating income: -11453571.42857143
Net income: -12090476.19047619
Capital expenditures: 377380.95238095237
Operating cash flow: -10528571.42857143
Depreciation & amortization: 3276190.476190476
Net tangible assets: 18732142.85714286
Owner earnings: -9191666.666666666
Return on net tangible assets (%): -49.06895455989831
Buffett classification: The Gruesome
Stock price: 4.154761904761905
Shares outstanding: 39439421
Book value: 67514285.71428572
P/B ratio: 2.4270626902595573
Market cap (USD): 163861403.9166667
Debt to equity: 0.03778741712512343
Current ratio: 2.7715042804728904
Quick ratio: 2.276600081532817
Interest coverage ratio: -51.725806451612904
COGS to revenue (%): 28.685496365153142
R&D to revenue (%): 6.0481468239780725
SG&A to revenue (%): 61.64044809915386
Free cash flow (dilution-adjusted): -12008333.333333334
Buyback yield (%): 0
Retained earnings: -50594047.61904762
Inventory turnover: 1.9827018121911038
Receivables turnover: 5.235376696303229
Capitalized R&D asset: 6199253.623188406
ROCI (R&D-adjusted, %): -14.730095164006293
Rosenberg metric: 2.973935126611292
FCF margin (%): -30.053033011560004
Revenue growth (%): 104.38436244062844
Rule of 40 score: 74.33132942906843
Financial ratios for KURN.SW — annual report dated 2024-12-31
Total revenue: 94621111.1111111
Gross profit: 77684444.44444445
Operating income: -6255555.555555555
Net income: -5372222.222222222
Capital expenditures: 1371111.111111111
Operating cash flow: 3933333.333333333
Depreciation & amortization: 3301111.111111111
Net tangible assets: 29636666.666666664
Owner earnings: -3442222.222222222
Return on net tangible assets (%): -11.614741498894013
Buffett classification: The Gruesome
Stock price: 23.722222222222225
Shares outstanding: 39439421
Book value: 71578888.8888889
P/B ratio: 13.070763234814734
Market cap (USD): 935590709.2777779
Debt to equity: 0.030517998789214695
Current ratio: 2.1413735928091455
Quick ratio: 1.6895453355441137
Interest coverage ratio: -33.7125748502994
COGS to revenue (%): 17.899458659683653
R&D to revenue (%): 9.243884968118461
SG&A to revenue (%): 54.60608978499043
Free cash flow (dilution-adjusted): -3880000
Buyback yield (%): 0
Retained earnings: -34504444.44444444
Inventory turnover: 1.472042491549976
Receivables turnover: 5.79786220043573
Capitalized R&D asset: 12228898.550724637
ROCI (R&D-adjusted, %): -3.466636156365008
Rosenberg metric: 20.354154351395728
FCF margin (%): -4.100564825796452
Revenue growth (%): 136.80649902673497
Rule of 40 score: 132.70593420093851
Financial ratios for KURN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 29636666.666666664
Buffett classification: The Gruesome
Stock price: 23.722222222222225
Shares outstanding: 39439421
Book value: 71578888.8888889
P/B ratio: 13.070763234814734
Market cap (USD): 935590709.2777779
Debt to equity: 0.030517998789214695
Current ratio: 2.1413735928091455
Quick ratio: 1.6895453355441137
Buyback yield (%): 0
Retained earnings: -34504444.44444444
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for KURN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 34774802.099999994
Buffett classification: The Gruesome
Stock price: 34.025
Shares outstanding: 39439421
Book value: 76506361.19999999
P/B ratio: 17.540061747506037
Market cap (USD): 1341926299.5249999
Debt to equity: 0.023365339456243805
Current ratio: 2.250676151309696
Quick ratio: 1.7426549590604274
Buyback yield (%): 0
Retained earnings: -22109911.2
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LMT — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 904000000
Buffett classification: The Gruesome
Stock price: 315.43
Shares outstanding: 230790753
Market cap (USD): 72798327218.79001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LMT — annual report dated 2022-12-31
Total revenue: 65984000000
Gross profit: 8287000000
Operating income: 8348000000
Net income: 5732000000
Capital expenditures: 1670000000
Operating cash flow: 7802000000
Depreciation & amortization: 1404000000
Net tangible assets: -3973000000
Owner earnings: 5466000000
Return on net tangible assets (%): -137.5786559275107
Capex to operating income (%): 20.004791566842357
Buffett classification: The Great
Stock price: 443.1
P/E ratio: 17.840785529361483
Shares outstanding: 230790753
Book value: 9266000000
P/B ratio: 11.036410819587742
Market cap (USD): 102263382654.3
Debt to equity: 1.677854521908051
Current ratio: 1.3212689620444389
Quick ratio: 1.1268962044438848
Effective tax rate (%): 14.191616766467066
Interest coverage ratio: 13.39967897271268
COGS to revenue (%): 87.44089476236664
Free cash flow (dilution-adjusted): 5894000000
Buyback yield (%): 7.725150288354772
Retained earnings: 16943000000
Inventory turnover: 18.684261658031087
Receivables turnover: 4.45146056803616
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.566431487038088
FCF margin (%): 8.932468477206596
Rule of 40 score: 8.932468477206596
Financial ratios for LMT — annual report dated 2023-12-31
Total revenue: 67571000000
Gross profit: 8479000000
Operating income: 8507000000
Net income: 6920000000
Capital expenditures: 1691000000
Operating cash flow: 7920000000
Depreciation & amortization: 1430000000
Net tangible assets: -6176000000
Owner earnings: 6659000000
Return on net tangible assets (%): -107.82059585492227
Capex to operating income (%): 19.877747737157637
Buffett classification: The Great
Stock price: 424.01
P/E ratio: 14.141269823631502
Shares outstanding: 230790753
Book value: 6835000000
P/B ratio: 14.317130531021215
Market cap (USD): 97857587179.53
Debt to equity: 2.5543525969275787
Current ratio: 1.2116077227372026
Quick ratio: 1.0266871346755624
Effective tax rate (%): 14.546801679427018
Interest coverage ratio: 9.287117903930131
COGS to revenue (%): 87.4517174527534
Free cash flow (dilution-adjusted): 5964000000
Buyback yield (%): 6.131359021751039
Retained earnings: 15398000000
Inventory turnover: 18.867177522349937
Receivables turnover: 4.412079660463598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 23.95056167121822
FCF margin (%): 8.82627162540143
Revenue growth (%): 2.4051285160038796
Rule of 40 score: 11.23140014140531
Financial ratios for LMT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 557.67
Shares outstanding: 230790753
Market cap (USD): 128705079225.51
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LMT — annual report dated 2024-12-31
Total revenue: 71043000000
Gross profit: 6930000000
Operating income: 7013000000
Net income: 5336000000
Capital expenditures: 1685000000
Operating cash flow: 6972000000
Depreciation & amortization: 1559000000
Net tangible assets: -8615000000
Owner earnings: 5210000000
Return on net tangible assets (%): -60.475914103308185
Capex to operating income (%): 24.026807357764152
Buffett classification: The Great
Stock price: 466.5
P/E ratio: 20.176890231353074
Shares outstanding: 230790753
Book value: 6333000000
P/B ratio: 17.000455751539555
Market cap (USD): 107663886274.5
Debt to equity: 3.200694773409127
Current ratio: 1.1250772399588054
Quick ratio: 0.9461894953656025
Effective tax rate (%): 14.212218649517686
Interest coverage ratio: 6.769305019305019
COGS to revenue (%): 90.24534436890333
Free cash flow (dilution-adjusted): 5010000000
Buyback yield (%): 3.4366212553079074
Retained earnings: 14551000000
Inventory turnover: 18.455094991364422
Receivables turnover: 4.640906715442906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 19.37453380114374
FCF margin (%): 7.052067057978971
Revenue growth (%): 5.1382989744121
Rule of 40 score: 12.190366032391072
Financial ratios for LMT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 466.5
Shares outstanding: 230790753
Market cap (USD): 107663886274.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LMT — quarterly report dated 2025-03-31
Total revenue: 17963000000
Gross profit: 2323000000
Operating income: 2372000000
Net income: 1712000000
Capital expenditures: 454000000
Operating cash flow: 1409000000
Depreciation & amortization: 397000000
Net tangible assets: -6345000000
Owner earnings: 1655000000
Return on net tangible assets (%): -26.083530338849485
Capex to operating income (%): 19.139966273187184
Buffett classification: The Great
Stock price: 432
P/E ratio: 14.559229745327103
Shares outstanding: 230790753
Book value: 6683000000
P/B ratio: 14.918690003890468
Market cap (USD): 99701605296
Debt to equity: 3.0381565165344906
Current ratio: 1.0761787888799736
Quick ratio: 0.9063104734035021
Effective tax rate (%): 15.913555992141454
Interest coverage ratio: 8.850746268656716
COGS to revenue (%): 87.06786171574905
Free cash flow (dilution-adjusted): 895000000
Buyback yield (%): 0.7522446582212551
Retained earnings: 14773000000
Inventory turnover: 4.3456515698805225
Receivables turnover: 1.0755643374648225
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.685079758750915
FCF margin (%): 4.98246395368257
Rule of 40 score: 4.98246395368257
Financial ratios for LMT — quarterly report dated 2025-06-30
Total revenue: 18155000000
Gross profit: 734000000
Operating income: 748000000
Net income: 342000000
Capital expenditures: 351000000
Operating cash flow: 201000000
Depreciation & amortization: 399000000
Net tangible assets: -7988000000
Owner earnings: 390000000
Return on net tangible assets (%): -4.882323485227841
Capex to operating income (%): 46.92513368983957
Buffett classification: The Good
Stock price: 450.98
P/E ratio: 50.672840208344695
Shares outstanding: 230790753
Book value: 5334000000
P/B ratio: 19.512938467930258
Market cap (USD): 104082013787.94
Debt to equity: 4.056617922759655
Current ratio: 0.9849716678984972
Quick ratio: 0.8330869672333087
Effective tax rate (%): 17.985611510791365
Interest coverage ratio: 2.72992700729927
COGS to revenue (%): 95.95703662902781
SG&A to revenue (%): 0.5453043238777197
Free cash flow (dilution-adjusted): -231000000
Buyback yield (%): 0.4803903977287717
Retained earnings: 13259000000
Inventory turnover: 4.709651257096513
Receivables turnover: 0.9974178661685529
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.1671109050874957
FCF margin (%): -1.272376755714679
Revenue growth (%): 1.0688637755386072
Rule of 40 score: -0.20351298017607178
Financial ratios for LMT — quarterly report dated 2025-09-30
Total revenue: 18609000000
Gross profit: 2240000000
Operating income: 2280000000
Net income: 1619000000
Capital expenditures: 381000000
Operating cash flow: 3728000000
Depreciation & amortization: 428000000
Net tangible assets: -7075000000
Owner earnings: 1666000000
Return on net tangible assets (%): -23.547703180212014
Capex to operating income (%): 16.710526315789473
Buffett classification: The Great
Stock price: 489.65
P/E ratio: 30.76686419995916
Shares outstanding: 230790753
Book value: 6181000000
P/B ratio: 18.282914124971686
Market cap (USD): 113006692206.45
Debt to equity: 3.589872188966187
Current ratio: 1.1289283537912422
Quick ratio: 0.9657438843910507
Effective tax rate (%): 16.46026831785346
Interest coverage ratio: 7.972027972027972
COGS to revenue (%): 87.96281369229942
Free cash flow (dilution-adjusted): 3273000000
Buyback yield (%): 0.8849033455232166
Retained earnings: 14053000000
Inventory turnover: 4.366230994931982
Receivables turnover: 1.0458607317484403
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.112272800386038
FCF margin (%): 17.58826374334999
Revenue growth (%): 2.500688515560452
Rule of 40 score: 20.088952258910442
Financial ratios for LMT — annual report dated 2025-12-31
Total revenue: 75048000000
Gross profit: 7619000000
Operating income: 7731000000
Net income: 5017000000
Capital expenditures: 1649000000
Operating cash flow: 8557000000
Depreciation & amortization: 1687000000
Net tangible assets: -8897000000
Owner earnings: 5055000000
Return on net tangible assets (%): -56.8169045745757
Capex to operating income (%): 21.329711550898978
Buffett classification: The Great
Stock price: 478.01
P/E ratio: 21.98929396881204
Shares outstanding: 230790753
Book value: 6721000000
P/B ratio: 16.41426690098646
Market cap (USD): 110320287841.53
Debt to equity: 3.228686207409612
Current ratio: 1.0868652239125778
Quick ratio: 0.9358474394686094
Effective tax rate (%): 15.281999324552517
Interest coverage ratio: 6.915026833631485
COGS to revenue (%): 89.84783072167146
Free cash flow (dilution-adjusted): 6604000000
Buyback yield (%): 2.7193547612107043
Retained earnings: 14034000000
Inventory turnover: 19.13422247446084
Receivables turnover: 4.440184593539226
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.177920832762634
FCF margin (%): 8.799701524357745
Revenue growth (%): 5.63743085173768
Rule of 40 score: 14.437132376095425
Financial ratios for LMT — quarterly report dated 2025-12-31
Total revenue: 20321000000
Gross profit: 2322000000
Operating income: 2331000000
Net income: 1344000000
Capital expenditures: 463000000
Operating cash flow: 3219000000
Depreciation & amortization: 463000000
Net tangible assets: -8897000000
Owner earnings: 1344000000
Return on net tangible assets (%): -15.106215578284814
Capex to operating income (%): 19.862719862719864
Buffett classification: The Great
Stock price: 478.01
P/E ratio: 21.98929396881204
Shares outstanding: 230790753
Book value: 6721000000
P/B ratio: 16.41426690098646
Market cap (USD): 110320287841.53
Debt to equity: 3.228686207409612
Current ratio: 1.0868652239125778
Quick ratio: 0.9358474394686094
Effective tax rate (%): 12.214239059438276
Interest coverage ratio: 8.037931034482758
COGS to revenue (%): 88.57339697849515
Free cash flow (dilution-adjusted): 2667000000
Buyback yield (%): 0.6798386903026761
Retained earnings: 14034000000
Inventory turnover: 5.107548240635642
Receivables turnover: 1.2022837534019644
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.385426653883029
FCF margin (%): 13.124354116431277
Revenue growth (%): 9.199849535171154
Rule of 40 score: 22.32420365160243
Financial ratios for MRNA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 253.98
Shares outstanding: 396786259
Market cap (USD): 100775774060.81999
Buyback yield (%): 0.8504027956984831
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRNA — annual report dated 2022-12-31
Total revenue: 18875000000
Gross profit: 13459000000
Operating income: 9420000000
Net income: 8362000000
Capital expenditures: 400000000
Operating cash flow: 4981000000
Depreciation & amortization: 348000000
Net tangible assets: 19123000000
Owner earnings: 8310000000
Return on net tangible assets (%): 43.455524760759296
Capex to operating income (%): 4.246284501061571
Buffett classification: The Great
Stock price: 179.62
P/E ratio: 8.523170036065535
Shares outstanding: 396786259
Book value: 19123000000
P/B ratio: 3.7269647984929146
Market cap (USD): 71270747841.58
Debt to equity: 0.06275166030434555
Current ratio: 2.728214503351615
Quick ratio: 2.5354458663416617
Effective tax rate (%): 12.66840731070496
Interest coverage ratio: 324.82758620689657
COGS to revenue (%): 28.694039735099334
R&D to revenue (%): 17.456953642384107
SG&A to revenue (%): 5.997350993377483
Free cash flow (dilution-adjusted): 4355000000
Buyback yield (%): 4.67092054007862
Retained earnings: 18320000000
Inventory turnover: 5.707060063224446
Receivables turnover: 11.201780415430267
Capitalized R&D asset: 3295000000
ROCI (R&D-adjusted, %): 47.943320951987886
FCF margin (%): 23.072847682119203
Rule of 40 score: 23.072847682119203
Financial ratios for MRNA — annual report dated 2023-12-31
Total revenue: 8203000000
Gross profit: 2061000000
Operating income: -4239000000
Net income: -4714000000
Capital expenditures: 707000000
Operating cash flow: -3118000000
Depreciation & amortization: 621000000
Net tangible assets: 13758000000
Owner earnings: -4800000000
Return on net tangible assets (%): -34.888791975577846
Buffett classification: The Gruesome
Stock price: 99.45
Shares outstanding: 396786259
Book value: 13854000000
P/B ratio: 2.8483032667496753
Market cap (USD): 39460393457.55
Debt to equity: 0.08972138010682836
Current ratio: 3.4245439469320065
Quick ratio: 3.3575456053067994
Interest coverage ratio: -111.55263157894737
COGS to revenue (%): 57.2107765451664
R&D to revenue (%): 59.0637571620139
SG&A to revenue (%): 18.883335365110327
Free cash flow (dilution-adjusted): -4130000000
Buyback yield (%): 2.9219171401328112
Retained earnings: 13606000000
Inventory turnover: 23.23267326732673
Receivables turnover: 7.588344125809436
Capitalized R&D asset: 7052650000
ROCI (R&D-adjusted, %): -9.38108158439672
Rosenberg metric: -3.4591805766312596
FCF margin (%): -50.34743386565891
Revenue growth (%): -56.54039735099337
Rule of 40 score: -106.88783121665227
Financial ratios for MRNA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 66.83
Shares outstanding: 396786259
Market cap (USD): 26517225688.97
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRNA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 41.58
Shares outstanding: 396786259
Market cap (USD): 16498372649.22
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MRNA — annual report dated 2024-12-31
Total revenue: 4517000000
Gross profit: 1735000000
Operating income: -3945000000
Net income: -3561000000
Capital expenditures: 1051000000
Operating cash flow: -3004000000
Depreciation & amortization: 189000000
Net tangible assets: 10809000000
Owner earnings: -4423000000
Return on net tangible assets (%): -40.91960403367564
Buffett classification: The Gruesome
Stock price: 41.58
Shares outstanding: 396786259
Book value: 10901000000
P/B ratio: 1.51347331889001
Market cap (USD): 16498372649.22
Debt to equity: 0.06852582331896157
Current ratio: 3.671350861287398
Quick ratio: 3.618313689936537
Interest coverage ratio: -164.375
COGS to revenue (%): 32.410892185078595
R&D to revenue (%): 100.57560327651096
SG&A to revenue (%): 25.99070179322559
Free cash flow (dilution-adjusted): -4484000000
Buyback yield (%): 0
Retained earnings: 10045000000
Inventory turnover: 12.512820512820513
Receivables turnover: 7.6300675675675675
Capitalized R&D asset: 8876500000
ROCI (R&D-adjusted, %): -17.439839839839838
Rosenberg metric: -0.0672858617131063
FCF margin (%): -99.26942661058224
Revenue growth (%): -44.93477995855175
Rule of 40 score: -144.204206569134
Financial ratios for MRNA — quarterly report dated 2025-03-31
Total revenue: 107000000
Gross profit: 17000000
Operating income: -1050000000
Net income: -971000000
Capital expenditures: 117000000
Operating cash flow: -1037000000
Depreciation & amortization: 39000000
Net tangible assets: 9965000000
Owner earnings: -1049000000
Return on net tangible assets (%): -10.526843953838434
Buffett classification: The Gruesome
Stock price: 28.35
Shares outstanding: 396786259
Book value: 10066000000
P/B ratio: 1.1175134554589707
Market cap (USD): 11248890442.65
Debt to equity: 0.07401152394198292
Current ratio: 4.2182044887780545
Quick ratio: 4.138403990024938
Interest coverage ratio: -1050
COGS to revenue (%): 84.11214953271028
R&D to revenue (%): 800
SG&A to revenue (%): 198.13084112149534
Free cash flow (dilution-adjusted): -1279000000
Buyback yield (%): 0
Retained earnings: 9074000000
Inventory turnover: 0.703125
Receivables turnover: 0.34967320261437906
Capitalized R&D asset: 856000000
ROCI (R&D-adjusted, %): -4.009144641463142
FCF margin (%): -1195.3271028037384
Rule of 40 score: -1195.3271028037384
Financial ratios for MRNA — quarterly report dated 2025-06-30
Total revenue: 176000000
Gross profit: 18000000
Operating income: -907000000
Net income: -825000000
Capital expenditures: 3000000
Operating cash flow: -919000000
Depreciation & amortization: 57000000
Net tangible assets: 9299000000
Owner earnings: -771000000
Return on net tangible assets (%): -8.291214109043983
Buffett classification: The Gruesome
Stock price: 27.59
Shares outstanding: 396786259
Book value: 9399000000
P/B ratio: 1.1647337893190766
Market cap (USD): 10947332885.81
Debt to equity: 0.07883817427385892
Current ratio: 3.9255725190839694
Quick ratio: 3.7729007633587788
Interest coverage ratio: -907
COGS to revenue (%): 67.61363636363636
R&D to revenue (%): 397.7272727272727
SG&A to revenue (%): 130.6818181818182
Free cash flow (dilution-adjusted): -1052000000
Buyback yield (%): 0
Retained earnings: 8249000000
Inventory turnover: 0.49583333333333335
Receivables turnover: 0.3851203501094092
Capitalized R&D asset: 1273520000
ROCI (R&D-adjusted, %): -6.196178349750219
Rosenberg metric: 0.0011682242990654205
FCF margin (%): -597.7272727272727
Revenue growth (%): 64.48598130841121
Rule of 40 score: -533.2412914188616
Financial ratios for MRNA — quarterly report dated 2025-09-30
Total revenue: 1971000000
Gross profit: 795000000
Operating income: -260000000
Net income: -200000000
Capital expenditures: 33000000
Operating cash flow: -847000000
Depreciation & amortization: 52000000
Net tangible assets: 9231000000
Owner earnings: -181000000
Return on net tangible assets (%): -1.9607843137254901
Buffett classification: The Gruesome
Stock price: 25.83
Shares outstanding: 396786259
Book value: 9330000000
P/B ratio: 1.098498292601286
Market cap (USD): 10248989069.97
Debt to equity: 0.07867095391211147
Current ratio: 3.9250446162998216
Quick ratio: 3.7275431290898275
COGS to revenue (%): 10.50228310502283
R&D to revenue (%): 40.63926940639269
SG&A to revenue (%): 13.597158802638255
Free cash flow (dilution-adjusted): -1005000000
Buyback yield (%): 0
Retained earnings: 8049000000
Inventory turnover: 0.6234939759036144
Receivables turnover: 1.4139167862266857
Capitalized R&D asset: 1552480000
ROCI (R&D-adjusted, %): -2.0377884831080104
Rosenberg metric: 1.11
FCF margin (%): -50.98934550989346
Revenue growth (%): 1019.8863636363636
Rule of 40 score: 968.8970181264701
Financial ratios for MRNA — annual report dated 2025-12-31
Total revenue: 3304000000
Gross profit: 1054000000
Operating income: -3074000000
Net income: -2822000000
Capital expenditures: 192000000
Operating cash flow: -1873000000
Depreciation & amortization: 215000000
Net tangible assets: 8553000000
Owner earnings: -2799000000
Return on net tangible assets (%): -32.725359522974394
Buffett classification: The Gruesome
Stock price: 29.49
Shares outstanding: 396786259
Book value: 8650000000
P/B ratio: 1.3527429801052022
Market cap (USD): 11701226777.91
Debt to equity: 0.1508670520231214
Current ratio: 3.2934071464519374
Quick ratio: 3.2164066431806746
Interest coverage ratio: -307.4
COGS to revenue (%): 26.27118644067797
R&D to revenue (%): 94.79418886198548
SG&A to revenue (%): 30.811138014527845
Free cash flow (dilution-adjusted): -2558000000
Buyback yield (%): 0
Retained earnings: 7223000000
Inventory turnover: 5.673202614379085
Receivables turnover: 11.633802816901408
Capitalized R&D asset: 7774660000
ROCI (R&D-adjusted, %): -22.704460600790995
Rosenberg metric: -0.149900946511116
FCF margin (%): -77.42130750605327
Revenue growth (%): -26.85410670799203
Rule of 40 score: -104.2754142140453
Financial ratios for MRNA — quarterly report dated 2025-12-31
Total revenue: 1053000000
Gross profit: 224000000
Operating income: -857000000
Net income: -826000000
Capital expenditures: 39000000
Operating cash flow: 930000000
Depreciation & amortization: 67000000
Net tangible assets: 8553000000
Owner earnings: -798000000
Return on net tangible assets (%): -9.330059628200631
Buffett classification: The Gruesome
Stock price: 29.49
Shares outstanding: 396786259
Book value: 8650000000
P/B ratio: 1.3527429801052022
Market cap (USD): 11701226777.91
Debt to equity: 0.1508670520231214
Current ratio: 3.2934071464519374
Quick ratio: 3.2164066431806746
Interest coverage ratio: -107.125
COGS to revenue (%): 42.92497625830959
R&D to revenue (%): 73.59924026590693
SG&A to revenue (%): 29.24976258309592
Free cash flow (dilution-adjusted): 778000000
Buyback yield (%): 0
Retained earnings: 7223000000
Inventory turnover: 2.954248366013072
Receivables turnover: 3.7077464788732395
Capitalized R&D asset: 1542670000
ROCI (R&D-adjusted, %): -7.068185569859149
Rosenberg metric: -0.7128589263420724
FCF margin (%): 73.88414055080722
Revenue growth (%): -46.57534246575342
Rule of 40 score: 27.308798085053795
Financial ratios for MTB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 133.13
Shares outstanding: 144933000
Market cap (USD): 19294930290
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTB — annual report dated 2022-12-31
Total revenue: 8013000000
Net income: 1992000000
Capital expenditures: 214000000
Operating cash flow: 4574000000
Depreciation & amortization: 435000000
Net tangible assets: 16619000000
Owner earnings: 2213000000
Return on net tangible assets (%): 13.316084000240688
Buffett classification: The Gruesome
Stock price: 129.21
P/E ratio: 9.40100046686747
Shares outstanding: 144933000
Book value: 25318000000
P/B ratio: 0.739663201279722
Market cap (USD): 18726792930
Debt to equity: 0.2830002369855439
Effective tax rate (%): 23.736600306278714
COGS to revenue (%): 0
SG&A to revenue (%): 37.02733058779483
Free cash flow (dilution-adjusted): 4360000000
Buyback yield (%): 9.611896744564472
Retained earnings: 15754000000
Receivables turnover: 0.8973124300111982
Capitalized R&D asset: 0
FCF margin (%): 54.41158118058156
Rule of 40 score: 54.41158118058156
Financial ratios for MTB — annual report dated 2023-12-31
Total revenue: 9398000000
Net income: 2741000000
Capital expenditures: 256000000
Operating cash flow: 3905000000
Depreciation & amortization: 497000000
Net tangible assets: 18345000000
Owner earnings: 2982000000
Return on net tangible assets (%): 16.2551103843009
Buffett classification: The Gruesome
Stock price: 127.04
P/E ratio: 6.717361663626415
Shares outstanding: 144933000
Book value: 26957000000
P/B ratio: 0.6830243840189932
Market cap (USD): 18412288320
Debt to equity: 0.48970582779982935
Effective tax rate (%): 24.260845537441284
COGS to revenue (%): 0
SG&A to revenue (%): 36.39072143009151
Free cash flow (dilution-adjusted): 3649000000
Buyback yield (%): 3.2261063354888853
Retained earnings: 17524000000
Receivables turnover: 1.024751935448697
Capitalized R&D asset: 0
FCF margin (%): 38.82741008725261
Revenue growth (%): 17.284412829152625
Rule of 40 score: 56.11182291640523
Financial ratios for MTB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 169.45
Shares outstanding: 144933000
Market cap (USD): 24558896850
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTB — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 81000000
Buffett classification: The Gruesome
Stock price: 179.96
Shares outstanding: 144933000
Market cap (USD): 26082142680
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTB — annual report dated 2024-12-31
Total revenue: 9231000000
Net income: 2588000000
Capital expenditures: 216000000
Operating cash flow: 3610000000
Depreciation & amortization: 508000000
Net tangible assets: 20468000000
Owner earnings: 2880000000
Return on net tangible assets (%): 14.070744576900527
Buffett classification: The Gruesome
Stock price: 179.96
P/E ratio: 10.078107681607419
Shares outstanding: 144933000
Book value: 29027000000
P/B ratio: 0.8985476514968822
Market cap (USD): 26082142680
Debt to equity: 0.46870155372584144
Effective tax rate (%): 21.812688821752264
COGS to revenue (%): 0
SG&A to revenue (%): 36.594085147871304
Free cash flow (dilution-adjusted): 3394000000
Buyback yield (%): 2.8601944600664995
Retained earnings: 19079000000
Capitalized R&D asset: 0
FCF margin (%): 36.76741414797963
Revenue growth (%): -1.7769738242179187
Rule of 40 score: 34.99044032376171
Financial ratios for MTB — quarterly report dated 2025-03-31
Total revenue: 2306000000
Net income: 584000000
Capital expenditures: 25000000
Operating cash flow: 635000000
Depreciation & amortization: 130000000
Net tangible assets: 20433000000
Owner earnings: 689000000
Return on net tangible assets (%): 3.371996280526599
Buffett classification: The Gruesome
Stock price: 172.31
P/E ratio: 10.690670047089041
Shares outstanding: 144933000
Book value: 28991000000
P/B ratio: 0.8614192414887379
Market cap (USD): 24973405230
Debt to equity: 0.4137835880100721
Effective tax rate (%): 23.258869908015768
COGS to revenue (%): 0
SG&A to revenue (%): 40.4163052905464
Free cash flow (dilution-adjusted): 610000000
Buyback yield (%): 2.6267943596733123
Retained earnings: 19405000000
Capitalized R&D asset: 0
FCF margin (%): 26.452732003469208
Rule of 40 score: 26.452732003469208
Financial ratios for MTB — quarterly report dated 2025-06-30
Total revenue: 2386000000
Net income: 716000000
Capital expenditures: 26000000
Operating cash flow: 844000000
Depreciation & amortization: 124000000
Net tangible assets: 19976000000
Owner earnings: 814000000
Return on net tangible assets (%): 4.074889867841409
Buffett classification: The Gruesome
Stock price: 188.39
P/E ratio: 21.003021438461538
Shares outstanding: 144933000
Book value: 28525000000
P/B ratio: 0.9571929139351445
Market cap (USD): 27303927869.999996
Debt to equity: 0.5041191936897458
Effective tax rate (%): 23.422459893048128
COGS to revenue (%): 0
SG&A to revenue (%): 36.043587594300085
Free cash flow (dilution-adjusted): 818000000
Buyback yield (%): 3.915187606302448
Retained earnings: 19870000000
Capitalized R&D asset: 0
FCF margin (%): 34.28331936295054
Revenue growth (%): 3.469210754553339
Rule of 40 score: 37.75253011750388
Financial ratios for MTB — quarterly report dated 2025-09-30
Total revenue: 2493000000
Net income: 792000000
Capital expenditures: 36000000
Operating cash flow: 1001000000
Depreciation & amortization: 122000000
Net tangible assets: 20189000000
Owner earnings: 878000000
Return on net tangible assets (%): 4.34890286789836
Buffett classification: The Gruesome
Stock price: 193.35
P/E ratio: 13.395217758126194
Shares outstanding: 144933000
Book value: 28728000000
P/B ratio: 0.9754523652882205
Market cap (USD): 28022795550
Debt to equity: 0.5196324143692564
Effective tax rate (%): 22.731707317073173
COGS to revenue (%): 0
SG&A to revenue (%): 34.857601283594065
Free cash flow (dilution-adjusted): 965000000
Buyback yield (%): 1.4416834297604546
Retained earnings: 20392000000
Capitalized R&D asset: 0
FCF margin (%): 38.708383473726435
Revenue growth (%): 4.4844928751047775
Rule of 40 score: 43.19287634883121
Financial ratios for MTB — annual report dated 2025-12-31
Total revenue: 9632000000
Net income: 2851000000
Capital expenditures: 143000000
Operating cash flow: 3003000000
Depreciation & amortization: 498000000
Net tangible assets: 20648000000
Owner earnings: 3206000000
Return on net tangible assets (%): 15.526927547462224
Buffett classification: The Gruesome
Stock price: 198.7
P/E ratio: 10.101082813048054
Shares outstanding: 144933000
Book value: 29177000000
P/B ratio: 0.9870167289303219
Market cap (USD): 28798187100
Debt to equity: 0.4459334407238578
Effective tax rate (%): 22.778981581798483
COGS to revenue (%): 0
SG&A to revenue (%): 36.274916943521596
Free cash flow (dilution-adjusted): 2860000000
Buyback yield (%): 9.135991758314537
Retained earnings: 20882000000
Capitalized R&D asset: 0
FCF margin (%): 29.69269102990033
Revenue growth (%): 4.3440580652150365
Rule of 40 score: 34.03674909511537
Financial ratios for MTB — quarterly report dated 2025-12-31
Total revenue: 2437000000
Net income: 759000000
Capital expenditures: 56000000
Operating cash flow: 523000000
Depreciation & amortization: 122000000
Net tangible assets: 20648000000
Owner earnings: 825000000
Return on net tangible assets (%): 3.995544362650136
Buffett classification: The Gruesome
Stock price: 198.7
P/E ratio: 10.101082813048054
Shares outstanding: 144933000
Book value: 29177000000
P/B ratio: 0.9870167289303219
Market cap (USD): 28798187100
Debt to equity: 0.4459334407238578
Effective tax rate (%): 21.833161688980432
COGS to revenue (%): 0
SG&A to revenue (%): 34.181370537546165
Free cash flow (dilution-adjusted): 467000000
Buyback yield (%): 1.7431652841786
Retained earnings: 20882000000
Capitalized R&D asset: 0
FCF margin (%): 19.162905211325402
Revenue growth (%): -2.2462896109105497
Rule of 40 score: 16.91661560041485
Financial ratios for MTU.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.943181818181817
Shares outstanding: 38266334
Market cap (USD): 954484126.4772726
Buyback yield (%): 0.02369199836470494
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTU.PA — annual report dated 2022-12-31
Total revenue: 2512369148.9361706
Gross profit: 332286170.212766
Operating income: 90475531.91489363
Net income: 58568085.10638298
Capital expenditures: 76696808.5106383
Operating cash flow: -111134042.5531915
Depreciation & amortization: 58415957.44680852
Net tangible assets: 763759574.4680852
Owner earnings: 40287234.0425532
Return on net tangible assets (%): 5.27485813459176
Capex to operating income (%): 84.77077380742412
Buffett classification: The Gruesome
Stock price: 21.93617021276596
P/E ratio: 14.332324755331129
Shares outstanding: 38266334
Book value: 842106382.9787234
P/B ratio: 0.9968061435104475
Market cap (USD): 839416816.0425532
Debt to equity: 0.37626013795194424
Current ratio: 1.770608534635132
Quick ratio: 0.8409043527804576
Effective tax rate (%): 31.185940702964853
Interest coverage ratio: 10.11500951474786
COGS to revenue (%): 86.77399098164103
R&D to revenue (%): 1.4788110061411053
SG&A to revenue (%): 3.185473404563887
Free cash flow (dilution-adjusted): -210636170.21276596
Buyback yield (%): 0
Inventory turnover: 2.8542350879831972
Receivables turnover: 4.833110604029593
Capitalized R&D asset: 37153191.4893617
ROCI (R&D-adjusted, %): 10.560433557839504
FCF margin (%): -8.383965799849001
Rule of 40 score: -8.383965799849001
Financial ratios for MTU.PA — annual report dated 2023-12-31
Total revenue: 3190346666.6666665
Gross profit: 541856666.6666666
Operating income: 237414444.44444445
Net income: 159450000
Capital expenditures: 79645555.55555555
Operating cash flow: -58473333.33333333
Depreciation & amortization: 67483333.33333333
Net tangible assets: 889294444.4444444
Owner earnings: 147287777.77777776
Return on net tangible assets (%): 16.562318442210742
Capex to operating income (%): 33.54705554749547
Buffett classification: The Good
Stock price: 22.055555555555557
P/E ratio: 5.293102887704261
Shares outstanding: 38266334
Book value: 994646666.6666667
P/B ratio: 0.8485277071031366
Market cap (USD): 843985255.4444445
Debt to equity: 0.5277172686671536
Current ratio: 1.6259338973707549
Quick ratio: 0.7807693598255159
Effective tax rate (%): 26.06836506014786
Interest coverage ratio: 13.969207635983263
COGS to revenue (%): 83.0157433256992
R&D to revenue (%): 1.4058033400758956
SG&A to revenue (%): 3.224135865416228
Free cash flow (dilution-adjusted): -175180000
Buyback yield (%): 0.008425634293061653
Inventory turnover: 2.703859024240843
Receivables turnover: 4.4523920284326675
Capitalized R&D asset: 69742638.29787233
ROCI (R&D-adjusted, %): 19.36214542966962
Rosenberg metric: 5.640713167640207
FCF margin (%): -5.490939333656531
Revenue growth (%): 26.98558522013282
Rule of 40 score: 21.494645886476288
Financial ratios for MTU.PA — annual report dated 2024-12-31
Total revenue: 2766610416.666667
Gross profit: 520952083.3333334
Operating income: 204670833.33333334
Net income: 127002083.33333334
Capital expenditures: 83642708.33333334
Operating cash flow: 260421875
Depreciation & amortization: 82429166.66666667
Net tangible assets: 897057291.6666667
Owner earnings: 125788541.66666666
Return on net tangible assets (%): 14.022353180247915
Capex to operating income (%): 40.86694081960873
Buffett classification: The Good
Stock price: 15.843750000000002
P/E ratio: 4.773797511031644
Shares outstanding: 38266334
Book value: 1016428125
P/B ratio: 0.5964831298942068
Market cap (USD): 606282229.3125001
Debt to equity: 0.4443163406168046
Current ratio: 1.7035288371525092
Quick ratio: 0.7181158732096905
Effective tax rate (%): 29.418779668866506
Interest coverage ratio: 9.765606361829025
COGS to revenue (%): 81.17002378813424
R&D to revenue (%): 1.6391899534101972
SG&A to revenue (%): 4.195228366841795
Free cash flow (dilution-adjusted): 142768750
Buyback yield (%): 0
Inventory turnover: 2.4734700808415044
Receivables turnover: 5.38756574850348
Capitalized R&D asset: 87660053.19148937
ROCI (R&D-adjusted, %): 15.391955961643196
Rosenberg metric: -0.4660999628390915
FCF margin (%): 5.160421183262009
Revenue growth (%): -13.28182465019474
Rule of 40 score: -8.12140346693273
Financial ratios for MTU.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 897057291.6666667
Buffett classification: The Gruesome
Stock price: 15.843750000000002
Shares outstanding: 38266334
Book value: 1016428125
P/B ratio: 0.5964831298942068
Market cap (USD): 606282229.3125001
Debt to equity: 0.4443163406168046
Current ratio: 1.7035288371525092
Quick ratio: 0.7181158732096905
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MTU.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.68235294117647
Shares outstanding: 38266334
Market cap (USD): 906236827.5529412
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAS.L — annual report dated 2022-01-31
Total revenue: 89285333.33333333
Net income: 86541333.33333333
Capital expenditures: 0
Operating cash flow: -3470666.6666666665
Net tangible assets: 1052621333.3333334
Owner earnings: 86541333.33333333
Return on net tangible assets (%): 8.221506689331775
Buffett classification: The Gruesome
Stock price: 0.054
P/E ratio: 0.07841235787138323
Shares outstanding: 125665000
Book value: 1052621333.3333333
P/B ratio: 0.006446677247658544
Market cap (USD): 6785910
Debt to equity: 0
Effective tax rate (%): 0.04312070717959775
COGS to revenue (%): 0
SG&A to revenue (%): 2.952332596619079
Free cash flow (dilution-adjusted): -3470666.6666666665
Buyback yield (%): 350.7660235203041
Receivables turnover: 43.258397932816536
Capitalized R&D asset: 0
FCF margin (%): -3.8871632518965415
Rule of 40 score: -3.8871632518965415
Financial ratios for NAS.L — annual report dated 2023-01-31
Total revenue: -110404938.27160493
Net income: -112392592.59259258
Capital expenditures: 0
Operating cash flow: 4474074.074074074
Net tangible assets: 855995061.728395
Owner earnings: -112392592.59259258
Return on net tangible assets (%): -13.130051517546542
Buffett classification: The Gruesome
Stock price: 0.045308641975308636
Shares outstanding: 125665000
Book value: 855995061.7283951
P/B ratio: 0.006651569323695186
Market cap (USD): 5693710.4938271595
Debt to equity: 0
Free cash flow (dilution-adjusted): 4474074.074074074
Buyback yield (%): 45.100663922970675
Receivables turnover: -58.60288335517693
Capitalized R&D asset: 0
Revenue growth (%): -223.65405845484693
Rule of 40 score: -223.65405845484693
Financial ratios for NAS.L — annual report dated 2024-01-31
Total revenue: 4591139.240506329
Net income: 2718987.3417721516
Capital expenditures: 0
Operating cash flow: 11946835.443037974
Net tangible assets: 873708860.7594936
Owner earnings: 2718987.3417721516
Return on net tangible assets (%): 0.31120061428799095
Buffett classification: The Gruesome
Stock price: 0.04392405063291139
P/E ratio: 2.0300630819366856
Shares outstanding: 125665000
Book value: 873708860.7594936
P/B ratio: 0.006317568781420686
Market cap (USD): 5519715.822784809
Debt to equity: 0
Effective tax rate (%): 1.3774104683195594
COGS to revenue (%): 0
SG&A to revenue (%): 34.105321202095396
Free cash flow (dilution-adjusted): 11946835.443037974
Buyback yield (%): 120.94733825844779
Receivables turnover: 0.07984589983489267
Capitalized R&D asset: 0
FCF margin (%): 260.21505376344084
Rule of 40 score: 260.21505376344084
Financial ratios for NAS.L — quarterly report dated 2025-01-31
Capital expenditures: 0
Net tangible assets: 891880000
Buffett classification: The Gruesome
Stock price: 0.044875
Shares outstanding: 125665000
Book value: 891880000
P/B ratio: 0.006322842618962192
Market cap (USD): 5639216.875
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NAS.L — annual report dated 2025-01-31
Total revenue: 54093750
Net income: 52400000
Capital expenditures: 0
Operating cash flow: 12713750
Net tangible assets: 891880000
Owner earnings: 52400000
Return on net tangible assets (%): 5.875229851549536
Buffett classification: The Gruesome
Stock price: 0.044875
P/E ratio: 0.10761864265267175
Shares outstanding: 125665000
Book value: 891880000
P/B ratio: 0.006322842618962192
Market cap (USD): 5639216.875
Debt to equity: 0
Effective tax rate (%): 0.026233574205241944
COGS to revenue (%): 0
SG&A to revenue (%): 2.7452339688041594
Free cash flow (dilution-adjusted): 12713750
Buyback yield (%): 209.49274095793666
Receivables turnover: 8.370406189555126
Capitalized R&D asset: 0
FCF margin (%): 23.50317735413056
Revenue growth (%): 1078.220636889992
Rule of 40 score: 1101.7238142441224
Financial ratios for NAS.L — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 991308000
Buffett classification: The Gruesome
Stock price: 0.05146666666666666
Shares outstanding: 125665000
Book value: 991308000
P/B ratio: 0.006524267600651529
Market cap (USD): 6467558.666666666
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEO.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 13.425196850393702
Shares outstanding: 45991972
Market cap (USD): 617451277.6377953
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NEO.TO — annual report dated 2022-12-31
Total revenue: 470807352.9411764
Gross profit: 109829411.76470588
Operating income: 44005147.058823526
Net income: 19425000
Capital expenditures: 12760294.117647057
Operating cash flow: 2717647.058823529
Depreciation & amortization: 12293382.352941176
Net tangible assets: 268694117.6470588
Owner earnings: 18958088.23529412
Return on net tangible assets (%): 7.055639476334341
Capex to operating income (%): 28.997276388123044
Buffett classification: The Good
Stock price: 6.13235294117647
P/E ratio: 14.519382484669542
Shares outstanding: 45991972
Book value: 351208088.2352941
P/B ratio: 0.8030538424723067
Market cap (USD): 282039004.76470584
Debt to equity: 0.1046744116421679
Current ratio: 3.625682125588843
Quick ratio: 1.9722407922762393
Effective tax rate (%): 42.94921309259438
Interest coverage ratio: 66.20243362831859
COGS to revenue (%): 76.67211204782774
R&D to revenue (%): 3.2500491958431854
SG&A to revenue (%): 9.588972634617006
Free cash flow (dilution-adjusted): -11953676.470588233
Buyback yield (%): 0
Retained earnings: -4931617.647058823
Inventory turnover: 2.308064804280167
Receivables turnover: 7.255008158085569
Capitalized R&D asset: 15301470.588235293
ROCI (R&D-adjusted, %): 12.964597827284855
FCF margin (%): -2.538974040212526
Rule of 40 score: -2.538974040212526